LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC).

Authors :: Zhou, C.
Wu, L.
Fan, Y.
Wang, Z.
Liu, L.
Chen, G.
Zhang, L.
Huang, D.
Cang, S.
Yang, Z.
Zhou, J.
Li, B.
Li, J.
Fan, M.
Zhang, W.
Yang, W.
Wang, S.
Zhou, H.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1186-S1186. 1p.
Publication Year :: 2020

Subjects :: *NON-small-cell lung carcinoma
*GEMCITABINE
*PLATINUM
*METASTASIS

Full Text Access

Tools